Welcome to LookChem.com Sign In|Join Free
  • or
HENAN SUNLAKE ENTERPRISE CORPORATIONDutasteride 164656-23-9//file1.lookchem.com/300w/substances/2022-02-14-04/82829e09-66c3-4fbd-94cc-cc986877290d.png
qq

Communicate with Supplier:

Ms. summer
Ms. summer: What can I do for you?

Dutasteride 164656-23-9 CAS NO.164656-23-9

Min.Order Quantity:
1 Kilogram
Purity:
99%
Port:
China main port
Payment Terms:
D/A,D/P,T/T

Add to Inquiry Cart

Product Details

Keywords

  • Dutasteride
  • 164656-23-9
  • C27H30F6N2O2

Quick Details

  • ProName: Dutasteride 164656-23-9
  • CasNo: 164656-23-9
  • Molecular Formula: C27H30F6N2O2
  • Appearance: detailed in specifcations
  • Application: Aripiprazole Intermediate functional...
  • DeliveryTime: within 5days
  • PackAge: as needed
  • Port: China main port
  • ProductionCapacity: 500 Metric Ton/Month
  • Purity: 99%
  • Storage: Keep in dry and cool condition
  • Transportation: by air or sea
  • LimitNum: 1 Kilogram
  • MF: C13H21O3PS

Superiority

our services

1.certificate of analysis (coa)

2.material safety data sheet (msds)

3.route of synthesis (ros)

4.method of aanlysis (moa)

5.nuclear magnetic resonance (nmr)

6.packing pictures and loading video before loading

7.free sample

9.factory audit

10.strong after-sale service

company information

henan sunlake enterprise corporation is located in henan province , the central plain of china , which enjoys favorable geogeaphical position and convenient transportion, the com[any was established in june. 1998 , until now having more than 18 years experience in manufacturing & exporting chemical raw material .sunlake is a professional manufacturer engaged in producing and selling chemicals,including organic & inorganic chemicals , pigments & dyestuffs , water treatment chemicals , food & feed additives and others . these products have been being well exported to europe , southeast asia , the middle east , africa , south america and some other countries and areas.we sincerely welcome foreign friends to visit our plant for cooperation. with the idea of "quality first,credit priority, excellent service", we are highly acknowledged by customers for good quality and competitive price. more importantly , the company has a strong r & d team, who are professional engineers and scholars with ph. d. .so we are confident to serve you better with our high - quality products and professional team.we are taking great efforts to provide our customers with demanded goods and professional services, and continuously improve our core ability of competition and get the momentum for sustainable development, and finally make us being a reliable and professional wupplier in international market.we welcome any serious inquiries from all customers of the world, and sincerely hope to cooperate.

Details

dutasteride basic information
medicines to treat benign prostatic hyperplasia clinical evaluation application
product name: dutasteride
synonyms: (5alpha,17beta)-n-{2,5-bis(trifluoromethyl)phenyl}-3-oxo-4-azaandrost-l-ene-17-carboxamide;dutasteride;gg-745, gi-198745,;5α,17β)-n-[2,5-bis(trifluoromethyl)phenyl]-3-oxo-4- aza -androst-1-ene-17-carboxamide;duagen;(5a,17)-n-[2,5-bis(trifluoromethyl)phenyl]-3-oxo-4-azaandrost-1-ene-17-carboxamide;avodart;gi 198745
cas: 164656-23-9
mf: c27h30f6n2o2
mw: 528.53
einecs:
product categories: miscellaneous biochemicals;all inhibitors;inhibitors;intermediates & fine chemicals;pharmaceuticals;steroids;steroid and hormone;hormone drugs;api
mol file: 164656-23-9.mol
dutasteride structure
dutasteride chemical properties
mp 242-250°c
storage temp. -20°c freezer
safety information
msds information
dutasteride usage and synthesis
medicines to treat benign prostatic hyperplasia on october 9, 2002, dutasteride that was developed by gsk was approved by the us food and drug administration for the use in the treatment of prostate enlargement.
on june 19, 2008, gsk announced that the fda approved for the combination of idutasteride and tamsulosin in the treatment of prostate hyperplasia.
in china, on of two elderly men over the age of 60 have benign prostatic hyperplasia. it can cause urinary tract symptoms, including significant rise in frequency of urination, thin urine flow, bladder emptying difficulties, as well as nocturia. it even can cause serious complications, like acute urinary retention, reduce the patients’ life quality, and affect their social life.
dutasteride is the first and the only dual 5α reductase inhibitor to be used in the treatment of prostatic hyperplasia. it can improve urinary system symptom, reduce the onset of acute urinary retention and the risk of prostate surgery. tamsulosin is α receptor blockers

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)